“…In addition, DNA methylation, histone modifications, and microRNA application are named as regulatory approaches for TAM alteration at the epigenetic level. It has been thought that the additional studies in TAM alteration at the transcriptional, epigenetic, and metabolic levels may show a promising new horizon in the fight with many cancer types such as breast, colon, colorectal, lung, ovarian, pancreatic, prostate and skin cancers, glioma, myeloma, hepatocellular carcinoma, and many others as well [185,186]. Table 2 summarizes the most promising TAM-based novel therapy approaches and their involvement in specific cancers and their therapies.…”